COVID-19: Shortage of Pneumovax 23 pneumococcal vaccine until January
The Pneumovax 23 pneumococcal vaccine will be in short supply until January next year, due to a “surge in demand”, manufacturer Merck Sharp and Dohme (MSD) has told C+D.
The Pneumovax 23 pneumococcal vaccine will be in short supply until January next year, due to a “surge in demand”, manufacturer Merck Sharp and Dohme (MSD) has told C+D.